NSB, announcement out this morning ladies/lads. Been waiting for this.
Full Report on EmtinB for MS treatment received. NEW results show that EmtinB WHIPS Copaxone at cell survival and axonal regeneration.
$18M MC Company, should be $200M
Copaxone has $4B/annum sales. Teva Pharm (owner of Capaxone) will be acquiring this, as they did with several other MS drug companies over the last few years.
That 24.5c is going to get smoked on open, will see some shenanigans up to 50c, and see solid rerate into 40s in ST. Long term $2.00+.
This is the beginning of a long journey. Trade the trade.
Also, golden cross on daily happened yesterday! see below
NSB
NSB
NSB
https://www.youtube.com/watch?v=OFr74zI1LBMhttps://hotcopper.com.au/threads/day-trading-pre-market-open-july-20.5509108/?post_id=45973310